09:00-09:05 |
Welcome message
|
09:05-09:10 |
Congratulatory Message
|
09:10-10:50 |
Plenary1 : When Epidemiology and Image Meet Real-world Practice (English) : Yeon-Mok Oh
|
09:10-09:35 |
Pierre Ernst : Adverse Effect of Bronchodilator Medication in COPD&Asthma
|
09:35-10:00 |
Pierre Ernst : Pitfalls in observational pharmaco-epidemiology: The example of beta-blockers in COPD
|
10:00-10:25 |
Eric Hoffman : Differentiation of Severe and Non-Severe Asthma via Quantitative Computed Tomography
|
10:25-10:50 |
Eric Hoffman : Role of Sildenafil in Lowering Lung Inflammation During Smoking Cessation: A multispectral CT assessment of lung anatomy and perfused blood volume
|
10:50-11:00 |
Visit Exhibitors
|
11:00-12:40 |
Plenary 2 : New Area of Personalized Medicine in Airway Diseases (English) : Ki-Suck Jung
|
11:00-11:25 |
Craig Hersh : New genomic era in Airway Disease: Asthma-COPD Overlap
|
11:25-11:50 |
Craig Hersh : Omics and the search for Blood Biomarkers in COPD - Clinical Subtypes of COPD
|
11:50-12:15 |
Monica Kraft : Biomarkers for the phenotypes and endotypes of severe asthma
|
12:15-12:40 |
Monica Kraft : Microbiome in Mechanisms of Asthma
|
12:40-13:40 |
Luncheon Session by GSK: Do we know what to consider for optimal COPD treatment : Paul Jones
|
13:40-15:20 |
Airway Disease Research and Control Programs in Asia (English) : Tae-Bum Kim
|
13:40-14:05 |
Naoki Hasegawa : Bronchiectasis and Pulmonary NTM in Japan
|
14:05-14:30 |
Ching-Hsiung Lin : COPD Control Program in Taiwan
|
14:30-14:55 |
Hui Fang Lim : National Asthma Program-2 in Singapore
|
14:55-15:20 |
Joon Beom Seo : Recent update in quantitative imaging of airway disease
|
15:20-15:30 |
Visit Exhibitors
|
15:30-16:45 |
Molecular pathobiology and treatable traits in airway diseases (English) : Jung-Hyun Chang
|
15:30-15:55 |
Woo Jin Kim : Environmental influence and epigenetic alterations in COPD
|
15:55-16:20 |
Ratko Djukanovic : Targeting treatable traits in airway diseases
|
16:20-16:45 |
Ratko Djukanovic : Molecular fingerprinting in asthma
|